Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:KRTX

Karuna Therapeutics (KRTX) Stock Price, News & Analysis

Karuna Therapeutics logo

About Karuna Therapeutics Stock (NASDAQ:KRTX)

Advanced Chart

Key Stats

Today's Range
$329.83
$329.83
50-Day Range
$313.97
$329.83
52-Week Range
$158.38
$329.99
Volume
5 shs
Average Volume
832,048 shs
Market Capitalization
$12.58 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive KRTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Karuna Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

KRTX Stock News Headlines

Missed the Last 10,000% Surge? Here’s Your Next Chance
We’ve uncovered small-cap stocks that have delivered big wins—before the rest of the market caught on. We don’t rely on luck—we rely on data, trends, and research. Our team is constantly scanning the market to spot hidden opportunities before they explode. What if you could get alerts on high-potential companies—before the crowd?
Bristol Myers to Purchase Karuna
See More Headlines

KRTX Stock Analysis - Frequently Asked Questions

Karuna Therapeutics, Inc. (NASDAQ:KRTX) issued its earnings results on Thursday, February, 22nd. The company reported ($3.01) earnings per share (EPS) for the quarter, missing the consensus estimate of ($2.65) by $0.36. The firm's quarterly revenue was down 100.0% on a year-over-year basis.

Karuna Therapeutics (KRTX) raised $70 million in an initial public offering on Friday, June 28th 2019. The company issued 4,400,000 shares at $15.00-$17.00 per share. Goldman Sachs, Citigroup and Wells Fargo Securities acted as the underwriters for the IPO and Wedbush PacGrow was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Karuna Therapeutics investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Tesla (TSLA), Palo Alto Networks (PANW), Salesforce (CRM) and Netflix (NFLX).

Company Calendar

Last Earnings
2/22/2024
Today
7/21/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:KRTX
CIK
1771917
Fax
N/A
Employees
339
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($11.72)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$433.68 million
Net Margins
N/A
Pretax Margin
-66,209.48%
Return on Equity
-31.63%
Return on Assets
-30.38%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
19.31
Quick Ratio
19.31

Sales & Book Value

Annual Sales
$654 thousand
Price / Sales
19,239.07
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$33.24 per share
Price / Book
9.92

Miscellaneous

Outstanding Shares
38,148,000
Free Float
33,157,000
Market Cap
$12.58 billion
Optionable
Optionable
Beta
1.18
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:KRTX) was last updated on 7/21/2025 by MarketBeat.com Staff
From Our Partners